| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-95 |
Sentence |
denotes |
Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease. |
| T1 |
0-95 |
Sentence |
denotes |
Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease. |
| T2 |
96-266 |
Sentence |
denotes |
Fabry disease is a heritable lipid disorder caused by the low activity of α-galactosidase A and characterized by the systemic accumulation of globotriaosylceramide (Gb3). |
| T2 |
96-266 |
Sentence |
denotes |
Fabry disease is a heritable lipid disorder caused by the low activity of α-galactosidase A and characterized by the systemic accumulation of globotriaosylceramide (Gb3). |
| T3 |
267-459 |
Sentence |
denotes |
Recent studies have reported a structural heterogeneity of Gb3 in Fabry disease, including Gb3 isoforms with different fatty acids and Gb3 analogs with modifications on the sphingosine moiety. |
| T3 |
267-459 |
Sentence |
denotes |
Recent studies have reported a structural heterogeneity of Gb3 in Fabry disease, including Gb3 isoforms with different fatty acids and Gb3 analogs with modifications on the sphingosine moiety. |
| T4 |
460-534 |
Sentence |
denotes |
However, Gb3 assays are often performed only on the selected Gb3 isoforms. |
| T4 |
460-534 |
Sentence |
denotes |
However, Gb3 assays are often performed only on the selected Gb3 isoforms. |
| T5 |
535-665 |
Sentence |
denotes |
To precisely determine the total Gb3 concentration, here we established two methods for determining both Gb3 isoforms and analogs. |
| T5 |
535-665 |
Sentence |
denotes |
To precisely determine the total Gb3 concentration, here we established two methods for determining both Gb3 isoforms and analogs. |
| T6 |
666-922 |
Sentence |
denotes |
One was the deacylation method, involving Gb3 treatment with sphingolipid ceramide N-deacylase, followed by an assay of the deacylated products, globotriaosylsphingosine (lyso-Gb3) and its analogs, by ultra-performance LC coupled to tandem MS (UPLC-MS/MS). |
| T6 |
666-922 |
Sentence |
denotes |
One was the deacylation method, involving Gb3 treatment with sphingolipid ceramide N-deacylase, followed by an assay of the deacylated products, globotriaosylsphingosine (lyso-Gb3) and its analogs, by ultra-performance LC coupled to tandem MS (UPLC-MS/MS). |
| T7 |
923-1047 |
Sentence |
denotes |
The other method was a direct assay established in the present study for 37 Gb3 isoforms and analogs/isoforms by UPLC-MS/MS. |
| T7 |
923-1047 |
Sentence |
denotes |
The other method was a direct assay established in the present study for 37 Gb3 isoforms and analogs/isoforms by UPLC-MS/MS. |
| T8 |
1048-1269 |
Sentence |
denotes |
Gb3s from the organs of symptomatic animals of a Fabry disease mouse model were mainly Gb3 isoforms and two Gb3 analogs, such as Gb3(+18) containing the lyso-Gb3(+18) moiety and Gb3(-2) containing the lyso-Gb3(-2) moiety. |
| T8 |
1048-1269 |
Sentence |
denotes |
Gb3s from the organs of symptomatic animals of a Fabry disease mouse model were mainly Gb3 isoforms and two Gb3 analogs, such as Gb3(+18) containing the lyso-Gb3(+18) moiety and Gb3(-2) containing the lyso-Gb3(-2) moiety. |
| T9 |
1270-1370 |
Sentence |
denotes |
The total concentrations and Gb3 analog distributions determined by the two methods were comparable. |
| T9 |
1270-1370 |
Sentence |
denotes |
The total concentrations and Gb3 analog distributions determined by the two methods were comparable. |
| T10 |
1371-1516 |
Sentence |
denotes |
Gb3(+18) levels were high in the kidneys (24% of total Gb3) and the liver (13%), and we observed Gb3(-2) in the heart (10%) and the kidneys (5%). |
| T10 |
1371-1516 |
Sentence |
denotes |
Gb3(+18) levels were high in the kidneys (24% of total Gb3) and the liver (13%), and we observed Gb3(-2) in the heart (10%) and the kidneys (5%). |
| T11 |
1517-1671 |
Sentence |
denotes |
These results indicate organ-specific expression of Gb3 analogs, insights that may lead to a deeper understanding of the pathophysiology of Fabry disease. |
| T11 |
1517-1671 |
Sentence |
denotes |
These results indicate organ-specific expression of Gb3 analogs, insights that may lead to a deeper understanding of the pathophysiology of Fabry disease. |